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Abstract 
 
Bone tissues are continually being remodeled depending 
on the organic situation, with hard tissue resorption and 
neoformation. Homeostasis and inflammatory conditions 
concerning bone may bring about the activation of 
hematopoietic cells with the ability to generate or dissolve 
bone matrix for a number of organic needs. The 
mechanisms used by osteoclasts to resorb hard tissues 
and the basic cell to cell interactions, with the participation 
of immune cells such as lymphocytes, along with other 
substances, as well as bone composition are described in 
this review. 
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Resumo 
 
O tecido ósseo é continuamente remodelado dependendo 
da situação orgânica, com reabsorção dos tecidos duros e 
neoformação óssea. A homeostasia e condições 
inflamatórias envolvendo o osso podem ativar células 
hematopoiéticas com a capacidade de gerar ou dissolver a 
matriz óssea para uma grande variedade de necessidades 
orgânicas. Os mecanismos usados pelos osteoclastos para 
reabsorver tecidos duros e as interações básicas 
intercelulares, com a participação de células imunológicas 
tais como linfócitos, junto com outras substâncias, bem 
como a composição óssea são descritas nesta revisão. 
 
Palavras-chave: Tecido ósseo; Linfócitos T; Matriz óssea. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Aluno do mestrado, Faculdade de Odontologia de Pernambuco, Universidade de 
Pernambuco (UPE) 
 
2 Aluno do doutorado, Faculdade de Odontologia de Pernambuco (UPE) 
 
3 Professor Adjunto, Disciplina de Endodontia, Faculdade de Odontologia de 
Pernambuco , Doutor (UPE) 
 
4 Professor Adjunto, Disciplina de Patologia Bucal, Faculdade de Odontologia de 
Pernambuco, Doutor (UPE) 
 
Correspondência: Ângelo Barbosa de Resende 
Endereço: Rua Afonso Batista, 175, Apto 403, Espinheiro – CEP 52021-020, Recife 
– PE, Brasil. 
E-mail: angeloresende@ig.com.br 
 
Data de Submissão: 24/05/2011 
Data de Aceite: 06/03/2012 
 
 
 
Introduction 
  
The bone composition, the mechanisms used by osteoclasts 
to resorb hard tissue and cell interactions during the process of 
resorption are described in this literature review. The sources for 
information on the mechanisms of osteoclastic activity were books, 
LILACS, MEDLINE, Cochrane Library, SciELO,  BBO,  PubMed 
databases and the bibliographical references of the works selected, 
searching for studies which, potentially, could be included in this 
review. The words used in the search for relevant studies 
were:  (“osteoclast activity”) and (“odontology”). The search was 
accomplished in Portuguese and in English. With the aim of producing 
an updated literature review, only the studies published in English, 
Portuguese and Spanish from 1999 to 2011 were selected.  
 
Literature Review 
 
For a long time researchers have been trying to comprehend 
the formation and degradation of hard tissues, not only with the aim of 
understanding the course of certain illnesses, but also to understand 
the growing process of the vertebrates; particularly the degradation 
process, for the fact that many pathologic diseases affect both 
osseous and dental structures. It is known that the cells responsible 
for the reposition of newly formed hard tissues are called osteoblasts 
or odontoblasts, depending on which structures they form; the former 
generates osseous structures and the latter, dental structures. 
Osteoblasts are characterized by their morphology, ability to 
form bone matrix, capacity for calcification of bone matrix and high 
alkaline phosphatases activity on the outer surface of the cell. Another 
possible property is the increasing of intracellular cAMP production in 
the presence of parathormone (PTH). (YOUNG et al., 2005; LYRITIS; 
BOSCAINOS, 2001; KWON, 2010). Internal signaling systems 
translate many external stimuli to a narrow range of internal signals or 
second messengers (MARANGALOU; GHALICHI; OUCHAKI, 2009). 
cAMP and cGMP are two second messengers associated with bone 
remodeling (REITAN; RYGH, 2006). Bone cells, in response to 
hormonal and mechanical stimuli, produce cAMP in vivo and in vitro.  
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Seemingly, bone or dental degradation have been a 
challenge for researchers, especially as for what concerns a condition 
known as root resorption, a pathologic process which recognizes and 
destroys dental structures while trigger immune cells. The attention is 
turned to the osteoclasts (degradation of osseous tissues) and 
odontoclasts (degradation of dental tissues). 
  It has been reported that the composition of calcified tissue 
is similar to a precipitate formed from salt solutions supersaturated of 
calcium phosphate. Both bone and precipitated of calcium phosphate 
present similar x-ray diffraction patterns characteristic of the apatite 
structure (HORVATH, 2006). Carbonate is present in bone and in the 
precipitate formed from salt solutions even when the calcium 
carbonate solubility product is not exceeded (DALAPICULA et al., 
2006). The substance which is the first to be formed both in 
calcification and in precipitation of the salt solution is dicalcium 
phosphate which can be rapidly converted to a basic calcium 
phosphate. Bone contains abundant amounts of transforming growth 
factor β (TGFβ), which includes TGFβ1, activins, inhibins, and bone 
morphogenetic protein (KATAGIRI; TAKAHASHI, 2002). This small 
polypeptide is produced by several cell types, such as fibroblasts and 
osteoblasts, and is deposited in the extracellular bone matrix in a 
latent form. The richest sources of TGFβ are platelets and bone, and it 
attracts monocytes and fibroblasts, and stimulates angiogenesis in 
vitro (VIÑALS; POUYSSÉGUR, 2001). 
Collagens and proteoglycans have been considered the two 
major classes of extracellular matrix macromolecules in skeletal and 
dental tissues. An analysis of changes in these matrix constituents 
during cell differentiation and morphogenesis may lead to a better 
understanding of the biological role of these macromolecules in 
development. The transplantation of demineralized bone matrix from 
the rat diaphysis to subcutaneous sites, resulted in new endochondral 
bone formation accompanied by hematopoietic bone marrow 
differentiation in the newly formed tissue (SHOULDERS; RAINES, 
2009). 
The degradation and consequent removal of hard tissue are 
a cellular event brought about by giant multinucleated cells which 
seem to be formed through asynchronous fusion of mononuclear cells 
belonging to the macrophage lineage and originating from the 
hematopoietic system. These cells are named clasts and can be 
identified under the light microscope because of their size (50 to 
100µm), their multinucleation (2 to 10 nuclei per cell), and because 
they occupy shallow depressions known as Howship´s lacunae 
(THEILL; BOYLE; PENNINGER, 2002). 
 Changes in the width of periodontal ligament (PDL) cause 
changes in cell population and increases in cellular activity during 
stress caused mainly by orthodontic forces. There is an apparent 
disruption of collagen fibers in the PDL, with evidence of cell and 
tissue damage. Hyalinization may appear as a consequence of such 
damage. The first sign of hyalinization is the presence of pyknotic 
nuclei in cells, followed by areas of acellularity, or cell-free zones. The 
resolution of the problem starts when cellular elements such as 
macrophages, foreign body giant cells, and osteoclasts of adjacent 
undamaged areas invade the necrotic tissue. These cells also resorb 
the underside of bone immediately adjacent to the necrotic PDL area 
and remove it together with the necrotic tissue. This process is known 
as undermining resorption (LEE; MOTURI; LEE, 2009; MABUCHI; 
MATSUZAKA; SHIMONO, 2002). 
Before the last decade, little was known regarding the 
ontogeny of osteoclasts or how these cells could resorb bone. There 
has been doubt whether clasts could degrade both organic and 
inorganic phases of bone (BLAIR; ATHANASOU, 2004). Ultimate 
proof that the osteoclast is of myeloid ontogeny came with the 
capacity to generate these resorptive cells in culture of pure 
populations of mononuclear phagocytes (YANG et al., 2001). 
Therefore, when it comes to mention the clastic cells, the macrophage 
lineage is indirectly mentioned as well. 
The osteoclast shares many characteristics with other 
macrophage polykaryons; however it is a unique cell. Those features 
distinguishing the osteoclast are expression of calcitonin receptors, 
the capacity to degrade bone and, in so doing, produce lacunae 
resorption, abundant synthesis of tartrateresistant acid phosphatase 
and distinct polarization, the latter, forming a unique ruffled membrane 
at the osteoclast-bone interface. Under the electron microscope, 
multinucleated osteoclasts exhibit a unique set of morphologic 
characteristics. Adjacent to the mineralized surface their cell 
membrane is thrown into a myriad of deep folds that form a brush 
border sometimes visible by light microscopy. Surrounding the brush 
border, the plasma membrane is closely apposed to the mineralized 
surface (within 0.2 to 0.5 nm), and the adjacent cytoplasm, devoid of 
cell organelles, is filled with fibrilar contractile proteins. This clear or 
sealing zone not only attaches the cells to the mineralized surface but 
also (by sealing the periphery of the brush border) isolates a 
microenvironment between them and the mineralized surface. The 
cells organelles consist of many nuclei, each surrounded by multiple 
Golgi complexes, an array of mitochondria and free polysomes, a 
rough endoplasmic reticulum, many coated transport vesicles, and 
numerous vacuolar structures. It has been known for years that 
osteoclasts are rich in acid phosphatases as well as other lysosomal 
enzymes. Several light microscopic investigations suggest that the 
osteoclast, fibroblast, foreign body giant cell, macrophage, and 
endothelial cells are involved in phagocytosis of collagen during 
resorption (PARRENO; HART, 2009).  
The concentration of enzymes, however, is not associated 
with lysosomal structures as in most other cells. Instead, it is known 
that the enzymes are synthesized in the rough endoplasmic reticulum, 
transported to the Golgi complexes, and from there, in coated 
transport vesicles, moved to the brush border (where by a process of 
exocytosis, their release occurs into the sealed compartment adjacent 
to the mineralized surface). Biochemical investigations have shown 
that during remodeling of tissues hydrolytic enzymes (such as acid 
hydrolases) increase many times (MORALES; ZHAO;LEFRANCOIS, 
1999; PERRENO; HART, 2009). Another recognized feature of 
osteoclasts is the presence of a proton pump associated with the 
ruffled border, pumping hydrogen ions into the sealed compartment 
(LUNDQUIST, 2002; GOLDBERG et al., 2011).  
The sequence of resorptive events might be resumed as the 
following: attachment of clasts to the mineralized surface; creation of a 
sealed acidic environment through action of the proton pump, 
demineralizing and exposing the organic matrix; degradation of this 
exposed organic matrix to its constituent amino acids by the action of 
released enzymes such as acid phosphatase and cathepsin B, and; 
uptake of mineral ions and amino acids by the cell. The resorptive 
cells of dental hard tissue (odontoclasts) are similar in most respects 
to osteoclasts although maybe somewhat smaller. Odontoclasts 
possess endocytotic vesicles containing liberated apatite crystals, 
which suggests that demineralization in the resorptive environment is 
not as complete as occurs in relation to osteoclasts (TEN CATE, 
2008). 
The activation of clasts is not a single event and takes place 
in association with other cell types such as lymphocytes. The 
interaction of the immune cells as well as cytokines and chemokines 
constitutes the main defense mechanism of a host. They are some of 
the substances used by the immunological cells to communicate. With 
special interest for the interaction with clasts is the fact that only 
interleukin (IL)-1α has a potent capacity, as far as it is known, to 
increase root resorption with odontoclastic activities (RIVOLLIER et 
al., 2004). IL-1 is the most potent among them, which directly 
stimulates osteoclast function through IL-1 type 1 receptor, expressed 
by osteoclasts. Secretion of IL-1 is triggered by various stimuli, 
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including neurotransmitters, bacterial products, other cytokines, and 
mechanical forces (NANCI; BOSSHARDT, 2006). Its actions include 
attracting leukocytes and stimulating fibroblasts, cells, osteoclasts, 
and osteoblasts to promote bone resorption and inhibit bone 
formation. Osteoblasts are target cells for IL-1, which in turn conveys 
messages to osteoclasts to resorb bone (NANCI; BOSSHARDT, 
2006).  Suda et al. (1999) reported increased levels of IL-8 at PDL 
tension sites and proposed it to be a triggering factor for bone 
remodeling. As the studies concerning root resorption continued, 
some researchers have tried to associate its origins with an specific 
antigen, present in the dentin, which would trigger the immunologic 
system.  
Other substances like prostaglandins also seem to play a 
role in the activation of osteoclasts. Klein-Nulend et al. (2003) 
suggested that prostaglandins are important mediators of mechanical 
stress. This finding was followed by the work of Sekhavat et al. (2002) 
who found an increase in osteoclast numbers after a local injection of 
prostaglandins into the paradental tissues of rodents. Other study 
showed the reduced rate of tooth movement after the administration of 
indomethocin, an anti-inflammatory agent and a specific inhibitor of 
prostaglandin synthesis (RAMOS; FURQUIM; CONSOLARO, 2005). 
Other studies carried out in animals have identified the role of 
prostaglandins (PGE1 and PGE2) in stimulating bone resorption 
(BRETCHER, 2006; WISE; KING, 2008). They have reported a direct 
action of prostaglandins on osteoclasts in increasing their numbers 
and their capacity to form a ruffled border and effect bone resorption. 
Like other bone resorbing agents, PGE2 also stimulates osteoblastic 
cell differentiation and new bone formation, coupling bone resorption 
in vitro. 
A great variety of chemically different substances seem to 
play important roles in bone remodeling. Growth factors (platelet-
derived growth factors), hormones (PTH), and interleukins as well as 
other cytokines with the capacity to induce PGE2 production, are able 
to alter bone remodeling (KALE et al., 2004). Another study evaluated 
the effects of prostacyclin and thromboxane A2 in orthodontic tooth 
movement and osteoclastic activity on rats. It was found that these 
analogues increase the number of multinuclear osteoclasts, 
osteoclastic bone resorption, and the rate of orthodontic tooth 
movement (GURTON et al., 2004). 
A cascade of events begins when the lymphocytes 
recognize and activate other cellular types to differentiate in order to 
eliminate the “nonself” structures once they are exposed to the 
immunologic system. As for what concerns dentin, odontoclasts are 
the main cellular type recruited in root resorption. As they come from 
the lineage of the macrophage, they play an important role in the 
immune response, since of the ways for macrophages to be activated 
is by microbial products, such as endotoxins and cytokines from T 
cells, such as interferon (IFN)-γ, and by the recognition of foreign 
agents. When activated, they destroy microorganisms, secrate pro-
inflammatory cytokines and present the antigens to T auxiliary cells. 
Macrophages can also acquire different morphology in the varied 
tissues of the body, such as Kupffer cells in the liver, alveolar 
macrophages in the lung and osteoclasts in the bone, or even 
odontoclasts to destroy dental structures (HIDALGO, 2001). 
The hard tissues in the body (bone, cementum, enamel and 
dentin) have many similarities in their formation. They are all 
specialized connective tissues, and collagen (mainly type I) plays a 
large role in determining their structure. Although enamel is not a 
connective tissue and has no collagen involved in its makeup, its 
formation still follows many of the principles involved in the formation 
of hard connective tissue (YAMAAI et al., 2005). The bone mass of a 
mammalian organism is maintained due to the balanced activities of 
bone forming and bone resorbing cells. Bone marrow stromal cells 
and osteoblasts support osteoclastogenesis via the synthesis of 
receptor activator of NF-κB ligand (RANKL). RANKL binds to its cell 
membrane receptor (RANK) in osteoclast precursors. In the presence 
of macrophage colony stimulating factor (M-CSF), these events lead 
to differentiation of osteoclast precursors to mature and active 
osteoclasts. Osteoprotegerin (OPG), also produced by osteoblasts 
and stromal cells, is a soluble decoy receptor for RANKL. Soluble 
OPG blocks the effects of RANKL on osteoclast precursors by 
preventing its binding to RANK (KALFAS, 2001). With both 
substances available, the organism regulates the need of resorption 
or neoformation of bone. The TNF-related ligand RANKL (receptor 
activator of nuclear factor-Kappa ligand) and its two receptors, RANK 
and osteoprotegrin (OPG), have been implicated in the remodeling 
process. RANKL is a downstream regulator of osteoclast formation 
and activation, through which many hormones and cytokines produce 
their osteoresorptive effect. In the bone system, RANKL is expressed 
on osteoblast cell lineage and exerts its effect by binding the RANK 
receptor on osteoclast lineage cells. This binding leads to rapid 
differentiation of hematopoietic osteoclast precursors to mature 
osteoclasts (DRUGARIN et al., 2003). 
Activated T lymphocytes are emerging as regulators of bone 
cell function, particularly in chronic inflammatory diseases associated 
with bone loss (KONG et al., 1999; TAKAYANAGI et al., 2000). They 
can synthesize RANKL and induce osteoclast formation and activity in 
vitro. Co-cultures of murine or human mitogen-activated T 
lymphocytes with osteoclast precursors result in the formation of 
multiple functional osteoclasts (GILLESPIE, 2007; KOTAKE et al., 
2001). Nevertheless, other methods of T-cell activation can result in 
complete inhibition of osteoclastogenesis, because IFN-γ is secreted 
by activated T cells, and is a known inhibitor of osteoclastogenesis 
(TAKAYANAGI et al., 2000). 
Chronic inflammatory conditions, such as rheumatoid 
arthritis, periodontal disease, and inflammatory bowel disease, are 
associated with decreased bone mass (COMPSTON, 2003; 
PEREIRA; PEREIRA, 2004). By using adoptive transfer experiments, 
it has been shown that T lymphocytes appear to be crucial in 
periapical bone loss associated with periodontal disease (BAKER 
2001; TAUBMAN; KAWAI, 2001). The effects of activated T 
lymphocytes on osteoclastogenesis are complex, and depend on the 
method of T-cell activation. The inhibition of osteoclastogenesis by 
activated T cells involves IFN-γ (and possibly other factors), but not 
OPG. This information should be helpful in interpreting the results of 
work examining the effects of T lymphocytes on osteoclast formation. 
 
Conclusions 
 
The balance of bone mass in living mammalian organisms is 
maintained by the action of osteoblasts and osteoclasts. Although 
many of the biological activities of the latter have been partially 
understood, further studies are necessary to comprehend the 
fundamentals of these cells, as well as the consequences that they 
may bring, not only for the establishment of illnesses, but also to 
enhance healing. 
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